Peptidoglycan-associated lipoprotein contributes to the virulence of Acinetobacter baumannii and serves as a vaccine candidate

Genomics. 2023 Mar;115(2):110590. doi: 10.1016/j.ygeno.2023.110590. Epub 2023 Mar 1.

Abstract

The role of peptidoglycan-associated lipoprotein (Pal) in A. baumannii pathogenesis remains unclear. Here, we illustrated its role by constructing a pal deficient A. baumannii mutant and its complementary strain.Transcriptome analysis of the WT and pal mutant revealed a total of 596 differentially expressed genes. Gene Ontology analysis revealed that pal deficiency caused the downregulation of genes related to material transport and metabolic processes. The pal mutant showed a slower growth and was sensitive to detergent and serum killing compared to WT strain, whereas, the complemented pal mutant showed rescued phenotype. The pal mutant caused decreased mortality in mice pneumonia infection compared to WT strain, while the complemented pal mutant showed increased mortality. Mice immunized with recombinant Pal showed 40% protection against A. baumannii-mediated pneumonia. Collectively, these data indicate Pal is a virulence factor of A. baumannii and may serve as a potential target for preventive or therapeutic interventions.

Keywords: A. baumannii; Differentially expressed genes; Metabolism; Peptidoglycan-associated lipoprotein; Pneumonia; Virulence factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii* / genetics
  • Acinetobacter baumannii* / metabolism
  • Animals
  • Lipoproteins / genetics
  • Lipoproteins / metabolism
  • Mice
  • Peptidoglycan / genetics
  • Peptidoglycan / metabolism
  • Pneumonia*
  • Vaccines* / metabolism
  • Virulence / genetics

Substances

  • Peptidoglycan
  • Vaccines
  • Lipoproteins